Zobrazeno 1 - 10
of 129
pro vyhledávání: '"SHUICHIRO MARUOKA"'
Autor:
Shoko Kotera, MD, Shuichiro Maruoka, MD, PhD, Yusuke Kurosawa, MD, PhD, Hiroyuki Arai, MD, Shiho Yamada, MD, PhD, Asami Fukuda, MD, PhD, Yutaka Kozu, MD, PhD, Hisato Hiranuma, MD, Reiko Ito, MD, PhD, Fumio Shaku, MD, PhD, Yasuhiro Gon, MD, PhD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 3, Pp 100247- (2024)
Background: Dysfunctional breathing (DB) is a clinical condition characterized by irregular breathing patterns presenting a sensation of dyspnea and a feeling of chest tightness. DB is a known comorbidity of asthma that is difficult to control, leadi
Externí odkaz:
https://doaj.org/article/aa71601062be4a8d88eea29660631de7
Autor:
Takashi Oki, Yutaka Kozu, Mamiko Hoshi, Yasunori Itoda, Naho Furusho, Ryosuke Ozoe, Yusuke Jinno, Akifumi Hirata, Yusuke Kurosawa, Shiho Yamada, Asami Fukuda, Mari Hikichi, Sotaro Shikano, Kenichi Sugaya, Hisato Hiranuma, Shuichiro Maruoka, Yasuhiro Gon
Publikováno v:
Sleep Science, Vol 17, Iss 02, Pp e143-e150 (2024)
Objective Leptin is an appetite-suppressing hormone released by adipose tissue that plays an important role in severe obstructive sleep apnea syndrome (OSAS). However, it is unclear whether leptin levels are a useful biomarker for this syndrome. The
Externí odkaz:
https://doaj.org/article/75af7ff4b2da4559933c04a2e7ea8362
Autor:
Chihiro Miya, Marni E. Cueno, Ryuta Suzuki, Shuichiro Maruoka, Yasuhiro Gon, Tadayoshi Kaneko, Yoshiyuki Yonehara, Kenichi Imai
Publikováno v:
FEBS Open Bio, Vol 11, Iss 2, Pp 446-455 (2021)
Porphyromonas gingivalis (Pg) is a periodontopathic pathogen that may affect MUC5AC‐related mucus hypersecretion along airway epithelial cells. Here, we attempted to establish whether Pg virulence factors (lipopolysaccharide, FimA fimbriae, gingipa
Externí odkaz:
https://doaj.org/article/176fd0caf75549cfb45cb0a6177a8852
Autor:
Toshihiro Shirai, Keita Hirai, Yasuhiro Gon, Shuichiro Maruoka, Kenji Mizumura, Mari Hikichi, Kunihiko Itoh, Shu Hashimoto
Publikováno v:
Allergology International, Vol 70, Iss 1, Pp 136-139 (2021)
Externí odkaz:
https://doaj.org/article/22ca3ba15ee54c46bafeb899dd27816c
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Omalizumab, a human immunoglobulin (Ig)G1 antibody against IgE, is a therapeutic agent for bronchial asthma. The Global Initiative for Asthma guidelines indicate that the use of omalizumab should be considered as an option in step 5 of treatment for
Externí odkaz:
https://doaj.org/article/0030a2e6a49d4bedb83715127d3d1f22
Autor:
Mai Takahashi, Kenji Mizumura, Yasuhiro Gon, Tetsuo Shimizu, Yutaka Kozu, Sotaro Shikano, Yuko Iida, Mari Hikichi, Shinichi Okamoto, Kota Tsuya, Asami Fukuda, Shiho Yamada, Kaori Soda, Shu Hashimoto, Shuichiro Maruoka
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
Although the pathogenesis of pulmonary fibrosis remains unclear, it is known to involve epithelial injury and epithelial-mesenchymal transformation (EMT) as a consequence of cigarette smoke (CS) exposure. Moreover, smoking deposits iron in the mitoch
Externí odkaz:
https://doaj.org/article/47ee0e9e6b0c4c088d638bf9371ca749
Autor:
Sotaro Shikano, Yasuhiro Gon, Shuichiro Maruoka, Tetsuo Shimizu, Yutaka Kozu, Yuko Iida, Mari Hikichi, Mai Takahashi, Shinichi Okamoto, Kota Tsuya, Asami Fukuda, Kenji Mizumura, Shu Hashimoto
Publikováno v:
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Acute respiratory distress syndrome (ARDS) is a life-threatening disease; however, its treatment has not yet been fully established. The progression of ARDS is considered to be mediated by altered intercellular communication betwe
Externí odkaz:
https://doaj.org/article/251147e5e31b411a9dd954965d1aef40
Autor:
Yasuhiro Gon, Reiko Ito, Shuichiro Maruoka, Kenji Mizumura, Yutaka Kozu, Hisato Hiranuma, Yuko Iida, Sotaro Shikano, Shu Hashimoto
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 13, Iss 1, Pp 1-4 (2017)
Abstract Background Omalizumab is a human IgG1 antibody against IgE used as a therapy for sever asthmatic patients with asthma. According to the guidelines of the Global Initiative for Asthma, omalizumab is an add-on drug at treatment step 5 that is
Externí odkaz:
https://doaj.org/article/01c36d03f7184352819d948e6d33e691
Autor:
Yasuhiro Gon, Reiko Ito, Shuichiro Maruoka, Kenji Mizumura, Yutaka Kozu, Hisato Hiranuma, Yuko Iida, Mari Hikichi, Sotaro Shikano, Shu Hashimoto
Publikováno v:
Allergology International, Vol 67, Iss 2, Pp 283-285 (2018)
Externí odkaz:
https://doaj.org/article/9ce8c7701da74d499701195331e58dcd
Autor:
Yasuhiro Gon, Shuichiro Maruoka, Reiko Ito, Kenji Mizumura, Yutaka Kozu, Hisato Hiranuma, Tomohiro Hattori, Mai Takahashi, Mari Hikichi, Shu Hashimoto
Publikováno v:
Allergology International, Vol 66, Iss 4, Pp 624-626 (2017)
Externí odkaz:
https://doaj.org/article/3b5d05bacf42494c90646a1a56d6e487